在Al-Medina Al-Monawwara的喘患者中使用非处方支气管扩展剂
Anas Khalil1, May M Almouteri2, Samah F Alraddadi2
1Internal Medicine, Taibah University, Madinah, SAU.
Cureus
|February 27, 2024
概括
沙特阿拉伯的许多喘患者在没有处方的情况下使用非处方 (OTC) 支气管扩展剂,增加了急诊室的访问. 这种过度使用短效β-激动剂 (SABA) 表明喘控制不良,需要进行干预.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 喘是一种广泛的慢性呼吸道疾病,需要谨慎管理.
- 在喘患者中,自用非处方 (OTC) 支气管扩展剂的自我治疗是常见的.
- 过度使用非处方支气管扩展剂可能会导致不良反应,并可能掩盖潜在的喘严重程度.
研究的目的:
- 为了确定在沙特阿拉伯Al-Medina Al-Monawwara的喘患者中使用OTC支气管扩展剂的患病率.
- 为了突出与非处方支气管扩展剂过度使用相关的风险.
- 促使卫生当局解决这一公共卫生问题.
主要方法:
- 一项在Al-Medina Al-Monawwara的多家医院进行的横截面观察研究.
- 在2021年9月至2023年2月期间,从419名喘患者收集的数据.
- 用于参与者招聘的便利抽样方法.
主要成果:
- 86.4%的参与者被处方喘吸入器,但13.6%使用它们没有处方.
- 只有46.3%的参与者总是通过处方获得短效支气管扩展剂;其余的人使用OTC选项.
- 非处方支气管扩展剂的使用与急诊室访问的风险增加有关.
结论:
- 该研究揭示了该地区喘患者中OTC支气管扩展剂使用率很高.
- 没有处方的短效β-激动剂 (SABA) 的增加使用可能表明喘控制不足.
- 需要卫生当局的紧急关注,以减轻与非处方支气管扩展剂过度使用相关的风险,并改善喘管理.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
01:26COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
303
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
303
01:23Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K